Please use this identifier to cite or link to this item:
https://accedacris.ulpgc.es/handle/10553/50717
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lekamwasam, S. | en_US |
dc.contributor.author | Adachi, J. D. | en_US |
dc.contributor.author | Agnusdei, D. | en_US |
dc.contributor.author | Bilezikian, J. | en_US |
dc.contributor.author | Boonen, S. | en_US |
dc.contributor.author | Borgström, F. | en_US |
dc.contributor.author | Cooper, C. | en_US |
dc.contributor.author | Perez, A. Diez | en_US |
dc.contributor.author | Eastell, R. | en_US |
dc.contributor.author | Hofbauer, L. C. | en_US |
dc.contributor.author | Kanis, J. A. | en_US |
dc.contributor.author | Langdahl, B. L. | en_US |
dc.contributor.author | Lesnyak, O. | en_US |
dc.contributor.author | Lorenc, R. | en_US |
dc.contributor.author | McCloskey, E. | en_US |
dc.contributor.author | Messina, O. D. | en_US |
dc.contributor.author | Napoli, N. | en_US |
dc.contributor.author | Obermayer-Pietsch, B. | en_US |
dc.contributor.author | Ralston, S. H. | en_US |
dc.contributor.author | Sambrook, P. N. | en_US |
dc.contributor.author | Silverman, S. | en_US |
dc.contributor.author | Sosa, M. | en_US |
dc.contributor.author | Stepan, J. | en_US |
dc.contributor.author | Suppan, G. | en_US |
dc.contributor.author | Wahl, D. A. | en_US |
dc.contributor.author | Compston, J. E. | en_US |
dc.date.accessioned | 2018-11-24T18:17:32Z | - |
dc.date.available | 2018-11-24T18:17:32Z | - |
dc.date.issued | 2012 | en_US |
dc.identifier.issn | 1862-3522 | en_US |
dc.identifier.uri | https://accedacris.ulpgc.es/handle/10553/50717 | - |
dc.description.abstract | The use of glucocorticoids in the treatment of medical disorders can lead to rapid bone loss and increased risk of fragility fracture. Updated clinical guidelines are needed that accommodate recent advances in fracture risk assessment and new pharmacological interventions to reduce fracture risk. This document serves as an appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Archives of Osteoporosis | en_US |
dc.source | Archives of Osteoporosis[ISSN 1862-3522],v. 7, p. 25-30 | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 3207 Patología | en_US |
dc.subject.other | Glucocorticoids | en_US |
dc.subject.other | Bone mineral density | en_US |
dc.subject.other | Fracture | en_US |
dc.subject.other | FRAX | en_US |
dc.subject.other | Bone protective therapy | en_US |
dc.title | An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis | en_US |
dc.type | info:eu-repo/semantics/Article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1007/s11657-012-0070-7 | en_US |
dc.identifier.scopus | 84876297687 | - |
dc.contributor.authorscopusid | 6506925663 | - |
dc.contributor.authorscopusid | 35228654500 | - |
dc.contributor.authorscopusid | 7006445748 | - |
dc.contributor.authorscopusid | 19641646600 | - |
dc.contributor.authorscopusid | 7005178155 | - |
dc.contributor.authorscopusid | 55887500100 | - |
dc.contributor.authorscopusid | 36041345700 | - |
dc.contributor.authorscopusid | 57192228805 | - |
dc.contributor.authorscopusid | 7101980830 | - |
dc.contributor.authorscopusid | 7006185414 | - |
dc.contributor.authorscopusid | 7102759272 | - |
dc.contributor.authorscopusid | 35229491800 | - |
dc.contributor.authorscopusid | 56769681100 | - |
dc.contributor.authorscopusid | 7005713798 | - |
dc.contributor.authorscopusid | 56134366000 | - |
dc.contributor.authorscopusid | 6602895446 | - |
dc.contributor.authorscopusid | 15058192300 | - |
dc.contributor.authorscopusid | 6603774236 | - |
dc.contributor.authorscopusid | 7102615949 | - |
dc.contributor.authorscopusid | 7103142193 | - |
dc.contributor.authorscopusid | 7202729055 | - |
dc.contributor.authorscopusid | 7004134221 | - |
dc.contributor.authorscopusid | 7102755080 | - |
dc.contributor.authorscopusid | 22936240100 | - |
dc.contributor.authorscopusid | 35735337800 | - |
dc.contributor.authorscopusid | 7103089586 | - |
dc.description.lastpage | 30 | en_US |
dc.description.firstpage | 25 | en_US |
dc.relation.volume | 7 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.description.numberofpages | 6 | en_US |
dc.utils.revision | Sí | en_US |
dc.date.coverdate | Diciembre 2012 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.sjr | 0,471 | - |
dc.description.sjrq | Q2 | - |
dc.description.scie | SCIE | - |
item.fulltext | Sin texto completo | - |
item.grantfulltext | none | - |
crisitem.author.dept | GIR SIANI: Ingeniería biomédica aplicada a estimulación neural y sensorial | - |
crisitem.author.dept | IU Sistemas Inteligentes y Aplicaciones Numéricas | - |
crisitem.author.orcid | 0000-0001-6845-2933 | - |
crisitem.author.parentorg | IU Sistemas Inteligentes y Aplicaciones Numéricas | - |
crisitem.author.fullName | Sosa Henríquez,Manuel José | - |
Appears in Collections: | Artículos |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.